Although highly popular now, the first GLP-1-based medication named Exenatide (Byetta) was approved by the FDA in 2005 to treat type 2 diabetes by improving insulin response
Learn More Thirumalini Dasari, MD Obesity Medicine +1 more BRG Select Provider Kyle Schwab, MD, FACP, DABSM, DABOM Sleep Medicine +2 more BRG Select Provider Jolie Relle, PA-C Medical Weight Loss BRG Select Provider Express Care Medical Weight Loss A self-pay, no-insurance-required option for patients who want quick access to GLP-1 therapy as part of a weight loss plan conveniently located at our Dutchtown & Walker Express Care locations
Potential Kidney Benefits: Some evidence suggests GLP-1s may have protective effects on kidney function in diabetes patients
However, as part of that, the gallbladder empties less frequently and more slowly
Informed consent was obtained from all participants
Women with PCOS face increased risks of developing type 2 diabetes, with some studies suggesting the risk is up to four times higher than women without the condition